Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors

Published:2011-07-13 Issue:17 Volume:17 Page:5774-5782
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

LoRusso Patricia M.,Jimeno Antonio,Dy Grace,Adjei Alex,Berlin Jordan,Leichman Lawrence,Low Jennifer A.,Colburn Dawn,Chang Ilsung,Cheeti Sravanthi,Jin Jin Y.,Graham Richard A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma;Expert Review of Clinical Pharmacology;2023-11-23

2. Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation;Expert Opinion on Drug Safety;2023-06-20

3. The current clinical approach to difficult-to-treat basal cell carcinomas;Expert Review of Anticancer Therapy;2023-01-02

4. Pyridine ring as an important scaffold in anticancer drugs;Recent Developments in the Synthesis and Applications of Pyridines;2023

5. Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma;Cancers;2022-07-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP